From the Professor..., page-134

"The last time I popped into the IMU threads was in the lead up to the well hated SPP in late 2023. I loved that SPP and bought my full $30k allocation when around 50% was passed up. I would have taken more if I was able to!"

Hey mate while I appreciate your contrarian and opportunity cost theories. I just want to understand your complete U turn since SPP. From buy held to sell held since SPP. Because some would argue Imu has become more mature as a company by diversifying its cancer cure eggs by bringing in and developing azercell, vaxina, oncalytics and onCARlytics and targets specific and niche cancers like bileduct.

Are you saying none of the above trials are goanna work????? Coz the way I see it since SPP imu has only advanced in its products and product lines........

just curious to know Ur rationale behind Ur sentiment U turn
Thanks
DYOR
SS